Eluxadoline for diarrhea-predominant IBS in children
Part of Digestive system clinical trials.
This trial tests whether eluxadoline can reduce symptoms of IBS with diarrhea (IBS-D) in children ages 6 to 17. It also asks families to track symptoms with a daily diary to measure whether treatment helps over the study period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is age 6 to 17 and has IBS-D (diarrhea-predominant irritable bowel syndrome).
- You (parent/guardian) and your child (assent) must agree to join before any study tests.
- Your child can complete the symptom check-ins (diary). If they’re 6–11 and can’t read well, a trained adult can do it by interview.
- For the last 2 weeks before randomization, your child must have enough abdominal pain and enough diarrhea-type stools as defined by the study rules.
- If your child is a girl who could get pregnant, she must not be pregnant or breastfeeding and must use birth control during the study and for about 30 days after the last dose.
- Your child must not have certain stomach/intestine conditions or past major bowel/gut surgeries that could explain symptoms differently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an oral medicine (eluxadoline) can help children and teens with IBS-D, a condition that causes stomach pain and frequent loose stools. It’s a Phase 3 study, meaning it’s designed to confirm benefits and safety.
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
This study tests whether a specific diet plan can improve symptoms in people with IBS that is not constipation (IBS-D or IBS-M). If you qualify, you’ll complete symptom questionnaires and follow the study diet for the trial period to see if symptoms improve.
This trial tests a combination of digestive enzymes and probiotics (called Enzymax DuoBiotics) to see if it can help people with irritable bowel syndrome (IBS) feel better. If you have IBS and are between 18 and 70, this study may be a good fit.
This study tests if psyllium, a fiber supplement, helps reduce belly pain and other symptoms in children with irritable bowel syndrome (IBS). It may be an option if standard treatments haven't worked well.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.